Brickell Biotech to Participate in September Virtual Investor Conferences
BOULDER, Colo., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that its management team will participate in the 4th Annual Lake Street Best Ideas Growth Conference and the Oppenheimer & Co. Fall Healthcare Life Sciences & MedTech Summit, both being held in September 2020.
Details are as follows:
Conference: 4th Annual Lake Street Best Ideas Growth Conference (virtual)
Conference: Oppenheimer & Co. Fall Healthcare Life Sciences & MedTech Summit (virtual)
A live webcast of the fireside chat at the Oppenheimer & Co. Fall Healthcare Life Sciences & MedTech Summit will also be available in the investors section of the Brickell Biotech website at https://ir.brickellbio.com/events-presentations. After the live webcast, the event will remain archived on the Brickell Biotech website for approximately 90 days.
About Brickell Bio
Brickell Investor Contact: